Related Experiment Video
Updated: Jun 23, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
Identification of therapeutic drug targets through genetically manipulated mice: are we getting it right?
1Stem Cell & Gene Targeting Laboratory, Structural Biology Program, The John Curtin School of Medical Research, ANU College of Medicine, Biology & Environment, The Australian National University, Canberra, ACT 0200, Australia. Klaus.Matthaei@anu.edu.au
Abstract:
A significant contribution to the identification of therapeutic targets in disease control and management has been made through the use of genetically modified mice in which specific gene function was altered. However, the genetic background of these mice can have a strong influence on the observed phenotype and, if not properly controlled, can lead to misinterpretation of data and incorrect conclusions as to the importance of particular genes in disease states. Nevertheless, it is becoming apparent that advantages may also ensue, since analysis of gene function in mixed (or a number of different) genetic backgrounds may more closely approximate the human genome and provide the potential to identify modifier genes and polymorphisms which influence the resulting phenotype of the target gene. A rigorous analysis of these strain-specific modifications of molecular function may thus afford a deeper understanding of the mechanisms underlying gene function and permit the development of more selective, specific and subtle molecular therapeutic approaches.
Insights
Genetically modified mice aid disease research, but genetic background matters. Analyzing diverse backgrounds can reveal gene interactions and improve therapeutic development for complex human diseases.
Area of Science:
- Genetics and Genomics
- Pharmacology and Therapeutics
- Disease Modeling
Background:
- Genetically modified mice are crucial for identifying therapeutic targets in disease control.
- The genetic background of these mice significantly influences observed phenotypes, potentially leading to data misinterpretation.
- Uncontrolled genetic backgrounds can obscure the true importance of specific genes in disease states.
Purpose of the Study:
- To highlight the influence of genetic background in genetically modified mouse models.
- To explore the potential advantages of analyzing gene function across mixed genetic backgrounds.
- To improve the understanding of gene function and develop precise molecular therapeutics.
Main Methods:
- Utilizing genetically modified mice with altered specific gene functions.
- Comparing phenotypes across different and mixed genetic backgrounds.
- Analyzing strain-specific modifications in molecular function.
Main Results:
- Genetic background strongly impacts the phenotype of genetically modified mice.
- Mixed genetic backgrounds may better approximate the human genome.
- Potential to identify modifier genes and polymorphisms influencing target gene phenotypes.
Conclusions:
- Rigorous analysis of strain-specific modifications deepens the understanding of gene function.
- Mixed genetic backgrounds offer advantages for identifying gene interactions.
- This approach can lead to more selective and effective molecular therapeutic strategies.
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

